Paper3957435
Efficacy of penicillin G, flucloxacillin, cefazolin, fusidic acid, vancomycin, rifampicin and fosfomycin in muscular infections in mice due to Staphylococcus aureus.
Haag R. Infection, 1986. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. Efficacy of penicillin G, flucloxacillin, cefazolin, fusidic acid, vancomycin, rifampicin and fosfomycin in muscular infections in mice due to Staphylococcus aureus. Papers, record 3957435. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3957435
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Efficacy of penicillin G, flucloxacillin, cefazolin, fusidic acid, vancomycin, rifampicin and fosfomycin in muscular infections in mice due to Staphylococcus aureus.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Bacterial Agents | Major topic |
| Muscular Diseases | Major topic |
| Staphylococcal Infections | Major topic |
| Animals | |
| Cefazolin | |
| Floxacillin | |
| Fosfomycin | |
| Fusidic Acid | |
| Mice | |
| Mice, Inbred Strains | |
| Microbial Sensitivity Tests | |
| Penicillin G | |
| Rifampin | |
| Species Specificity | |
| Staphylococcus aureus | |
| Vancomycin |
Source PubMed
References43
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4488470 | Fucidin-resistant staphylococci in current hospital practice. | J Med Microbiol | 1973 | https://conductscience.org/library/papers/4488470 | PubMed |
| 2 | 7116982 | Treatment of mice infected with methicillin-resistant Staphylococcus aureus. | Chemotherapy | 1982 | https://conductscience.org/library/papers/7116982 | PubMed |
| 3 | 6915076 | The role of antibiotic tolerance in the response to treatment of pyelonephritis due to Staphylococcus aureus in rats. | J Infect Dis | 1982 | https://conductscience.org/library/papers/6915076 | PubMed |
| 4 | 6092279 | In vitro activity of fosfomycin against methicillin-susceptible and methicillin-resistant Staphylococcus aureus. | Infection | 1984 | https://conductscience.org/library/papers/6092279 | PubMed |
| 5 | 7071562 | [Sensitivity of bacteria to chemotherapeutic agents (Zurich 1980). Part I. Bacteria isolated from hospital patients]. | Schweiz Med Wochenschr | 1982 | https://conductscience.org/library/papers/7071562 | PubMed |
| 6 | 475520 | Serious staphylococcal infections with strains tolerant to bactericidal antibiotics. | Arch Intern Med | 1979 | https://conductscience.org/library/papers/475520 | PubMed |
| 7 | 6520065 | The incidence and development of resistance in Staphylococcus aureus from three European countries. | J Antimicrob Chemother | 1984 | https://conductscience.org/library/papers/6520065 | PubMed |
| 9 | 6979313 | Variables in demonstrating methicillin tolerance in Staphylococcus aureus strains. | Antimicrob Agents Chemother | 1982 | https://conductscience.org/library/papers/6979313 | PubMed |
| 10 | 13877818 | [Staphylococcus strains naturally resistant to methicillin and 5-methyl-3-phenyl-4-iso-oxazolyl-penicillin]. | Ann Inst Pasteur (Paris) | 1962 | https://conductscience.org/library/papers/13877818 | PubMed |
| 11 | 7028601 | [Comparison of in vitro methods for the determination of the activity of fosfomycin with the efficacy determined in experimentally infected mice (author's transl)]. | Immun Infekt | 1981 | https://conductscience.org/library/papers/7028601 | PubMed |
| 12 | 349090 | Cefazolin and cephradine: relationship between antibacterial activity in vitro and in mice experimentally infected with Escherichia coli. | J Infect Dis | 1978 | https://conductscience.org/library/papers/349090 | PubMed |
| 13 | 3969311 | Chronic granulomatous disease: uptake and intracellular activity of fosfomycin in granulocytes. | Pediatr Res | 1985 | https://conductscience.org/library/papers/3969311 | PubMed |
| 14 | 6903495 | [Comparison of activity of fosfomycin, oxacillin and penicillin G against staphylococci and micrococci (author's transl)]. | Dtsch Med Wochenschr | 1980 | https://conductscience.org/library/papers/6903495 | PubMed |
| 15 | 6550616 | Resistance of methicillin-resistant staphylococcus aureus to third-generation cephalosporins. | J Infect Dis | 1983 | https://conductscience.org/library/papers/6550616 | PubMed |
| 16 | 6549772 | Vancomycin treatment of bacteremia caused by oxacillin-resistant Staphylococcus aureus: comparison with beta-lactam antibiotic treatment of bacteremia caused by oxacillin-sensitive Staphylococcus aureus. | J Infect Dis | 1983 | https://conductscience.org/library/papers/6549772 | PubMed |
| 17 | 6901593 | Treatment of experimental staphylococcal infections: effect of rifampin alone and in combination on development of rifampin resistance. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/6901593 | PubMed |
| 18 | 6320397 | [Selection of mutant rifampin-resistant Staphylococcus aureus during the therapeutic use of this antibiotic in combinations. 3 cases]. | Sem Hop | 1983 | https://conductscience.org/library/papers/6320397 | PubMed |
| 19 | 6570084 | Responses of tolerant and nontolerant Staphylococcus aureus strains to methicillin treatment in an experimental infection in mice. | Antimicrob Agents Chemother | 1984 | https://conductscience.org/library/papers/6570084 | PubMed |
| 20 | 6735962 | Effectiveness of cefamandole against methicillin-resistant strains of Staphylococcus aureus in vitro and in experimental infections. | J Antimicrob Chemother | 1984 | https://conductscience.org/library/papers/6735962 | PubMed |
| 21 | 5023643 | Killing of intraleukocytic Staphylococcus aureus by rifampin: in-vitro and in-vivo studies. | J Infect Dis | 1972 | https://conductscience.org/library/papers/5023643 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41182847 | Rifampicin as monotherapy for infections caused by Staphylococcus aureus: considerations for not applying 'breakpoints in brackets'. | J Antimicrob Chemother | 2025 | https://conductscience.org/library/papers/41182847 | PubMed |
| 10770759 | Pharmacodynamics of glycopeptides in the mouse peritonitis model of Streptococcus pneumoniae or Staphylococcus aureus infection. | Antimicrob Agents Chemother | 2000 | https://conductscience.org/library/papers/10770759 | PubMed |
| 2921087 | The microbiological efficacy of the combination of fosfomycin and vancomycin against clinically relevant staphylococci. | Infection | 1989 | https://conductscience.org/library/papers/2921087 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3957435
GET https://conductscience.org/api/papers/v1/3957435/references?page=2